Skip to content

Study · Animal study (in vivo) · mouse, tilapia and african catfish · 2017

1 result

Growth hormone releasing peptide-6 enhanced antibody titers against subunit antigens in mice (BALB/c), tilapia (Oreochromis niloticus) and African catfish (Clarias gariepinus).

Martínez R, Hernández L, Gil L, Carpio Y, Morales A, Herrera F, Rodríguez-Mallón A, Leal Y, Blanco A, Estrada MP

Vaccine1 Oct 2017Cited by 4 (Europe PMC)

PMID28893476 (opens in a new tab)DOI10.1016/j.vaccine.2017.07.060 (opens in a new tab)PepBankPUB-28893476
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In mice, tilapia and African catfish, GHRP‑6 increased antigen-specific antibody responses to co-injected protein and peptide antigens.

    In plain wordsIn mice, tilapia and African catfish, GHRP‑6 increased antibody responses to co-injected antigens.

    Peptide
    GHRP-6
    Outcome
    IncreaseAntigen-specific antibody response
    Study

    mice, tilapia and African catfishn: not reported in source

    subunit antigen immunization
    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    This peptide was able to increase the antigen-specific antibody response using heterologous proteins and peptides as antigens, which were also formulated in "water in oil" emulsions (Freund and Montanide).
    1 context sentence
    Summary · context
    In the present study, we evaluated the ability of GHRP-6 to enhance the humoral immune response against co-injected antigens in mice, tilapia and African catfish.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.